France· FR:60718902
LOXEN 10 mg/10 mL, solution injectable (I.V.)
A medicinal product containing nicardipine (chlorhydrate de), registered in France by LABORATOIRE XO.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- NICARDIPINE (CHLORHYDRATE DE)
- Manufacturer
- LABORATOIRE XO
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009331107725 ampoule(s) en verre brun de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nicardipine (chlorhydrate de) in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCardene IVBaxter Healthcare Corporation
- United KingdomCardene 20mg capsulesWaymade Healthcare Plc
- SpainFLUSEMIDE 20 mg COMPRIMIDOSLaboratorios Q Pharma S.L.
- BelgiumNicardipine Aguettant 10 mg/10 mlLaboratoire Aguettant
- SwitzerlandNicardipin Aguettant 10 mg/10 ml, solution injectableAguettant Suisse SA
- ItalyNICARDIPINA*30 cps 40 mg rilascio prolungatoMYLAN SpA
- NetherlandsCardene IV, 1 mg/ml oplossing voor infusieLaboratoire X.O.
- NorwayNicardipine HCl hikmaHikma
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Nicardipine Aguettant, Nicardipine Hikma
- Spain · Flusemide, Nerdipina Retard
- United Kingdom (Northern Ireland) · Nicardipine Hydrochloride Tillomed Laboratories, Nicardipine Laboratoire Aguettant
- Italy · Nicardipina Mylan Generics
- Luxembourg · Nicardipine Aguettant, Rydene Iv
- Netherlands · Cardene Iv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8ea08ed9-aa45-44d5-b74b-4da613d78b90 GET /v1/drugs/8ea08ed9-aa45-44d5-b74b-4da613d78b90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60718902",
"date_amm": "1988-06-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "NICARDIPINE (CHLORHYDRATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about nicardipine (chlorhydrate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.